Clover Health officer to sell 20,000 shares, $103K

An officer of CLOV has filed a Rule 144 notice to sell 20,000 shares of common stock, following smaller sales in the prior three months.

Available on EDGAR 09/14/2026 - 05:44 PM EDT Accepted by SEC EDGAR 09/14/2026 - 05:44 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CLOVER HEALTH INVESTMENTS, CORP. (CLOV) received a notice that officer Joseph Frank Oldakowski intends to sell 20,000 shares of common stock under Rule 144. The proposed sale, through Morgan Stanley Smith Barney LLC on NASDAQ, is valued at approximately $103,100 based on the figures disclosed. During the prior three months, Oldakowski sold 12,102 shares for about $58,769.73.

Key Figures

Shares proposed to be sold: 20,000 shares Aggregate value of proposed sale: $103,100.00 Shares sold in past 3 months: 12,102 shares +3 more

6 metrics

Shares proposed to be sold 20,000 shares Common stock under Rule 144 for CLOVER HEALTH INVESTMENTS, CORP.

Aggregate value of proposed sale $103,100.00 Total dollar amount associated with the 20,000 shares in the Rule 144 notice

Shares sold in past 3 months 12,102 shares Common stock sold on June 16, 2026 by Joseph Oldakowski

Value of past 3-month sales $58,769.73 Aggregate proceeds from 12,102 shares sold on June 16, 2026

Issuer phone number (201) 432-2133 Contact phone for CLOVER HEALTH INVESTMENTS, CORP.

Issuer SEC file number 001-39252 SEC file number for CLOVER HEALTH INVESTMENTS, CORP.

Key Terms

Rule 144, Restricted Stock, Securities To Be Sold, Securities Sold During The Past 3 Months

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 06/16/2026 | Restricted Stock | Issuer |"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities To Be Sold financial

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months financial

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for CLOV?

The filing discloses that officer Joseph Frank Oldakowski plans to sell 20,000 shares of CLOVER HEALTH INVESTMENTS, CORP. common stock under Rule 144, with an indicated aggregate value of about $103,100 through Morgan Stanley Smith Barney LLC on NASDAQ.

How many CLOV shares is the officer planning to sell under this Form 144?

The officer plans to sell 20,000 shares of CLOVER HEALTH INVESTMENTS, CORP. common stock. The securities are described as Restricted Stock acquired on June 16, 2026, and the proposed sale amount is reflected with an aggregate value of about $103,100.

What is the approximate value of the CLOV shares covered by the new Form 144?

The 20,000 CLOV shares covered by the notice have an indicated aggregate value of about $103,100. This figure appears in the securities information section and reflects the total dollar amount associated with the proposed sale under Rule 144.

What CLOV share sales has the officer made in the past three months?

In the past three months, 12,102 shares of CLOV common stock were sold by Joseph Oldakowski on June 16, 2026, for total proceeds of about $58,769.73. These prior sales are reported in the “Securities Sold During The Past 3 Months” section.

Who is the broker for the planned CLOV Rule 144 sale?

The planned sale of CLOV shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York. The filing associates this broker with the 20,000 common shares proposed to be sold on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002128814
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CLOVER HEALTH INVESTMENTS, CORP.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	(201) 432-2133
Name of Person for Whose Account the Securities are To Be Sold	JOSEPH OLDAKOWSKI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	103100.00	435441337	09/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/16/2026	Restricted Stock	Issuer			20000	06/16/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOSEPH OLDAKOWSKI 1209 Orange Street Wilmington DE 19801	Common	06/16/2026	12102	58769.73

144: Remarks and Signature

Remarks
Date of Notice	09/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joseph Frank Oldakowski
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)